 Theodore Alkousakis
Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 6 | 2019 | 830 | 1.270 |
Why?
| | Melanoma | 4 | 2019 | 730 | 1.160 |
Why?
| | Antimetabolites, Antineoplastic | 2 | 2018 | 91 | 1.130 |
Why?
| | Fluorouracil | 2 | 2018 | 197 | 1.090 |
Why?
| | Skin Diseases | 2 | 2018 | 143 | 1.030 |
Why?
| | Shiitake Mushrooms | 1 | 2021 | 2 | 0.750 |
Why?
| | Acute Generalized Exanthematous Pustulosis | 1 | 2021 | 4 | 0.750 |
Why?
| | Exanthema | 1 | 2021 | 74 | 0.700 |
Why?
| | Dermatologic Surgical Procedures | 1 | 2020 | 18 | 0.660 |
Why?
| | Ipilimumab | 1 | 2019 | 31 | 0.650 |
Why?
| | Alopecia Areata | 1 | 2019 | 11 | 0.650 |
Why?
| | Dermoscopy | 1 | 2018 | 10 | 0.590 |
Why?
| | Injections, Intralesional | 1 | 2018 | 33 | 0.580 |
Why?
| | Nevus, Pigmented | 1 | 2018 | 32 | 0.580 |
Why?
| | Photochemotherapy | 1 | 2018 | 32 | 0.570 |
Why?
| | Antineoplastic Agents, Immunological | 1 | 2019 | 181 | 0.560 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2018 | 86 | 0.550 |
Why?
| | Mitosis | 1 | 2018 | 180 | 0.540 |
Why?
| | Travel | 1 | 2017 | 122 | 0.530 |
Why?
| | Laser Therapy | 1 | 2018 | 129 | 0.510 |
Why?
| | Academic Medical Centers | 1 | 2017 | 483 | 0.460 |
Why?
| | Anxiety | 1 | 2020 | 976 | 0.400 |
Why?
| | Head and Neck Neoplasms | 1 | 2018 | 544 | 0.400 |
Why?
| | Aged, 80 and over | 6 | 2019 | 7066 | 0.290 |
Why?
| | Dermatologic Agents | 1 | 2025 | 65 | 0.220 |
Why?
| | Psoriasis | 1 | 2025 | 87 | 0.220 |
Why?
| | Patient Selection | 1 | 2025 | 660 | 0.180 |
Why?
| | Hypnosis | 1 | 2020 | 6 | 0.170 |
Why?
| | Mind-Body Therapies | 1 | 2020 | 6 | 0.170 |
Why?
| | Motion Pictures | 1 | 2020 | 18 | 0.160 |
Why?
| | Music | 1 | 2020 | 39 | 0.160 |
Why?
| | Prognosis | 2 | 2018 | 3773 | 0.160 |
Why?
| | Mitotic Index | 1 | 2018 | 26 | 0.150 |
Why?
| | Cicatrix, Hypertrophic | 1 | 2018 | 1 | 0.150 |
Why?
| | Skin Ulcer | 1 | 2018 | 13 | 0.150 |
Why?
| | Humans | 13 | 2025 | 129847 | 0.150 |
Why?
| | Antibodies, Monoclonal | 1 | 2025 | 1368 | 0.150 |
Why?
| | Drug Eruptions | 1 | 2017 | 27 | 0.140 |
Why?
| | Skin Diseases, Vesiculobullous | 1 | 2017 | 17 | 0.140 |
Why?
| | Biopsy, Needle | 1 | 2018 | 187 | 0.140 |
Why?
| | Area Under Curve | 1 | 2018 | 306 | 0.140 |
Why?
| | Upper Extremity | 1 | 2018 | 95 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2025 | 1368 | 0.130 |
Why?
| | Histiocytoma, Benign Fibrous | 1 | 2017 | 8 | 0.130 |
Why?
| | Task Performance and Analysis | 1 | 2018 | 173 | 0.130 |
Why?
| | Quality Improvement | 1 | 2025 | 1112 | 0.130 |
Why?
| | ROC Curve | 1 | 2018 | 504 | 0.130 |
Why?
| | Retrospective Studies | 3 | 2018 | 14553 | 0.130 |
Why?
| | Heparin | 1 | 2017 | 254 | 0.130 |
Why?
| | Aged | 4 | 2018 | 22107 | 0.120 |
Why?
| | Patient Satisfaction | 1 | 2020 | 639 | 0.120 |
Why?
| | Male | 9 | 2025 | 63759 | 0.120 |
Why?
| | Middle Aged | 5 | 2025 | 31177 | 0.120 |
Why?
| | Patient Education as Topic | 1 | 2020 | 743 | 0.120 |
Why?
| | Adult | 6 | 2025 | 35634 | 0.110 |
Why?
| | Lower Extremity | 1 | 2018 | 407 | 0.110 |
Why?
| | Leishmania major | 1 | 2014 | 8 | 0.110 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2014 | 10 | 0.110 |
Why?
| | Pain | 1 | 2020 | 791 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1434 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1690 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1847 | 0.100 |
Why?
| | Hemorrhage | 1 | 2017 | 680 | 0.100 |
Why?
| | Anticoagulants | 1 | 2017 | 637 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1989 | 0.100 |
Why?
| | Sex Factors | 1 | 2018 | 1973 | 0.100 |
Why?
| | Female | 6 | 2025 | 68829 | 0.080 |
Why?
| | Adolescent | 2 | 2018 | 20451 | 0.080 |
Why?
| | Cohort Studies | 1 | 2018 | 5444 | 0.070 |
Why?
| | Military Personnel | 1 | 2014 | 521 | 0.070 |
Why?
| | Risk Factors | 2 | 2017 | 9801 | 0.060 |
Why?
| | Skin Pigmentation | 1 | 2025 | 45 | 0.060 |
Why?
| | Young Adult | 2 | 2018 | 12467 | 0.060 |
Why?
| | Fasciotomy | 1 | 2003 | 14 | 0.050 |
Why?
| | Surgical Wound Dehiscence | 1 | 2003 | 23 | 0.050 |
Why?
| | Laparotomy | 1 | 2003 | 106 | 0.050 |
Why?
| | Abdominal Injuries | 1 | 2003 | 118 | 0.050 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2025 | 756 | 0.040 |
Why?
| | Sepsis | 1 | 2003 | 576 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2025 | 2739 | 0.030 |
Why?
| | Mohs Surgery | 1 | 2017 | 25 | 0.030 |
Why?
| | Animals | 1 | 2018 | 35409 | 0.030 |
Why?
| | Radiation Dosage | 1 | 2017 | 154 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2017 | 484 | 0.030 |
Why?
| | Fluconazole | 1 | 2014 | 18 | 0.030 |
Why?
| | Aminoquinolines | 1 | 2014 | 21 | 0.030 |
Why?
| | Iraq | 1 | 2014 | 52 | 0.030 |
Why?
| | Cryotherapy | 1 | 2014 | 16 | 0.030 |
Why?
| | Quality of Life | 1 | 2025 | 2695 | 0.030 |
Why?
| | Arm | 1 | 2014 | 107 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2003 | 2481 | 0.020 |
Why?
| | Anti-Infective Agents | 1 | 2014 | 249 | 0.020 |
Why?
| | United States | 1 | 2025 | 13913 | 0.020 |
Why?
| | Abdomen | 1 | 2003 | 119 | 0.010 |
Why?
| | Radiography, Interventional | 1 | 2003 | 105 | 0.010 |
Why?
| | Drainage | 1 | 2003 | 164 | 0.010 |
Why?
| | Postoperative Care | 1 | 2003 | 244 | 0.010 |
Why?
| | Surgical Wound Infection | 1 | 2003 | 283 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2003 | 2511 | 0.010 |
Why?
|
|
Alkousakis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|